Searched for
ORCHID PHARMA NEWS
Orchid Pharma shares in focus as U.S. FDA completes facility inspectionOrchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosp...- Stocks in news: Cyient, Waaree Energies, BSE, Tata Technologies, Orchid PharmaShares of IREDA and Tata Technologies will be in focus after an NSE release confirmed the inclusion of these in the futures and options seg...
- Stocks in news: Vodafone Idea, Hindalco, Nykaa, Hero MotoCorp, Marico, WiproJindal Stainless on Monday said it will manufacture customised stainless steel and speciality low-alloy steel sheets for defence projects o...
- Stocks in news: JSW Infra, Stanley Lifestyles, SAMHI Hotels, Bank Of Baroda, IREDAIndicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remain...
- Orchid Pharma gets EIR from USFDA for its Chennai facilityAs per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.
- Sensex jumps 199 pts to hit fresh record at 34,353, Nifty above 10,600Market is riding on the optimism and the real test would begin with the earnings season.
- Market Now: BSE Healthcare index up; Suven Life Sciences surges 12%Benchmark NSE Nifty50 index was up 40 points at 10,207, while BSE Sensex was up 115 points at 32,548.
- Market Now: BSE Healthcare index up; SMS Pharma surges 7%Nifty50 index was trading around 9,840, while Sensex was hovering near 31,550-level.
- Top pharma stocks have plunged up to 50%; time to buy on dips?Most experts said regulatory hurdles are going to be the biggest overhang for the sector and, hence, investors should remain selective.
- USFDA stringencies may be a positive for the pharma industry at large: Pashupati AdvaniI think that the bar is being raised in that industry both in cleanliness as well as in supply chain and quality of supply and APIs.
- Orchid Pharma gets EIR report from USFDA on inspection closureOrchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...
- Orchid Chemicals rallies over 8% on USFDA nod for Eszopiclone tabletsOrchid Chemicals Ltd rallied as much as 8.07 per cent in trade on Friday, after the pharma major received approval from the USFDA.
- Bullish on pharma sector: Sudip BandyopadhyayEven globally, look at what is happening in Pfizer, AstraZeneca we are seeing the impact of that in India today also.
- Mainstay gone, strides in for a rough rideThe company had earlier acquired assets, improved efficiencies and subsequently sold them at attractive valuations.
- Accumulate Strides Arcolab on every dip: Ashit SuriAshit Suri, Fundamental Research Analyst, JV Capital Services in an interview with ET Now talks about his pick from the pharma stocks.
- Sweet 'n' not-so-sweet pills kept pharma sector in good health'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry.
- Sweet 'n' not-so-sweet pills kept pharma sector in good health'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry. It saw hefty excise duty cu...
- Ranbaxy in strategic alliance with Orchid ChemicalsRanbaxy said the pact with Orchid involved multiple geographies and therapies for both finished dosage forms and active pharmaceutical ingr...
- Orchid plunges 12.5% on Ranbaxy silenceOrchid Chemicals’ shares plunged 12.5% or Rs 40 to Rs 279 on Thursday from Wednesday’s close of Rs 319 at BSE.
- Orchid may use warrants as defenceAs a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...
Load More
